Levadopa Related Compound A | CAS#27244-64-0 | amino acid derivative

MedKoo Cat#: 597363 | Name: Levadopa Related Compound A

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Levadopa Related Compound A is the 6-hydroxy derivative of the amino acid L-DOPA with neurotoxic properties. Studies show that exogenously administered 6-Hydroxy-L-DOPA is biotransformed by amino acid decarboxylase to the highly potent and catecholamine-selective neurotoxin, 6-Hydroxydopamine. The treatment of 6-Hydroxy-L-DOPA in rats resulted in the stimulation of acetylcholinesterase.

Chemical Structure

Levadopa Related Compound A

CAS#27244-64-0

Theoretical Analysis

MedKoo Cat#: 597363

Name: Levadopa Related Compound A

CAS#: 27244-64-0

Chemical Formula: C9H11NO5

Exact Mass: 213.0637

Molecular Weight: 213.19

Elemental Analysis: C, 50.71; H, 5.20; N, 6.57; O, 37.52

Price and Availability

Size	Price	Availability	Quantity
50mg	USD 500.00	2 Weeks
100mg	USD 850.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

6-Hydroxydopa, L-; Levadopa Related Compound A; L-Hydroxydopa;

IUPAC/Chemical Name

(S)-2-amino-3-(2,4,5-trihydroxyphenyl)propanoic acid

InChi Key

YLKRUSPZOTYMAT-YFKPBYRVSA-N

InChi Code

InChI=1S/C9H11NO5/c10-5(9(14)15)1-4-2-7(12)8(13)3-6(4)11/h2-3,5,11-13H,1,10H2,(H,14,15)/t5-/m0/s1

SMILES Code

N[C@@H](CC1=CC(O)=C(O)C=C1O)C(O)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Product Data

Product Data

Instruction

View handling instruction

Biological target:

Levadopa Related Compound A is the 6-hydroxy derivative of the amino acid L-DOPA with neurotoxic properties.

In vitro activity:

TBD

In vivo activity:

TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 213.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:

TBD

In vitro protocol:

TBD

In vivo protocol:

TBD

1: Luurtsema G, Boersma HH, Schepers M, de Vries AMT, Maas B, Zijlma R, de Vries EFJ, Elsinga PH. Improved GMP-compliant multi-dose production and quality control of 6-[(18)F]fluoro-L-DOPA. EJNMMI Radiopharm Chem. 2017;1(1):7. doi: 10.1186/s41181-016-0009-1. Epub 2016 Apr 4. PubMed PMID: 29564384; PubMed Central PMCID: PMC5843807. 2: Pinna A, Pontis S, Borsini F, Morelli M. Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease. Synapse. 2007 Aug;61(8):606-14. PubMed PMID: 17476684. 3: Yamato H, Kannari K, Shen H, Suda T, Matsunaga M. Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum. Neuroreport. 2001 May 8;12(6):1123-6. PubMed PMID: 11338177. 4: Kostrzewa RM, Kostrzewa JP, Brus R. Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum. Amino Acids. 2000;19(1):183-99. PubMed PMID: 11026489. 5: Zhu Z, Davidson VL. Identification of a new reaction intermediate in the oxidation of methylamine dehydrogenase by amicyanin. Biochemistry. 1999 Apr 13;38(15):4862-7. PubMed PMID: 10200175. 6: Kostrzewa RM, Brus R. Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor. Amino Acids. 1998;14(1-3):175-9. Review. PubMed PMID: 9871458. 7: Dove JE, Smith AJ, Kuchar J, Brown DE, Dooley DM, Klinman JP. Identification of the quinone cofactor in a lysyl oxidase from Pichia pastoris. FEBS Lett. 1996 Dec 2;398(2-3):231-4. PubMed PMID: 8977113. 8: McGuirl MA, McCahon CD, McKeown KA, Dooley DM. Purification and characterization of pea seedling amine oxidase for crystallization studies. Plant Physiol. 1994 Nov;106(3):1205-11. PubMed PMID: 7824646; PubMed Central PMCID: PMC159650. 9: Künig G, Hartmann J, Niedermeyer B, Deckert J, Ransmayr G, Heinsen H, Beckmann H, Riederer P. Excitotoxins L-beta-oxalyl-amino-alanine (L-BOAA) and 3,4,6-trihydroxyphenylalanine (6-OH-DOPA) inhibit [3H] alpha-amino-3- hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) binding in human hippocampus. Neurosci Lett. 1994 Mar 14;169(1-2):219-22. PubMed PMID: 7914016. 10: Künig G, Niedermeyer B, Krause F, Hartmann J, Deckert J, Ransmayr G, Heinsen H, Beckmann H, Riederer P. Interactions of neurotoxins with non-NMDA glutamate receptors: an autoradiographic study. J Neural Transm Suppl. 1994;43:59-62. PubMed PMID: 7533823. 11: Skaper SD, Fadda E, Facci L, Manev H. A semisynthetic glycosphingolipid (LIGA20) reduces 2,4, 5-trihydroxyphenylalanine neurotoxicity in primary neuronal cultures. Eur J Pharmacol. 1993 Oct 12;243(1):91-3. PubMed PMID: 8253129. 12: Karoum F, Chrapusta SJ, Egan MF, Wyatt RJ. Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study. J Neurochem. 1993 Oct;61(4):1369-75. PubMed PMID: 8104232. 13: Turowski PN, McGuirl MA, Dooley DM. Intramolecular electron transfer rate between active-site copper and topa quinone in pea seedling amine oxidase. J Biol Chem. 1993 Aug 25;268(24):17680-2. PubMed PMID: 8349651. 14: Mu D, Janes SM, Smith AJ, Brown DE, Dooley DM, Klinman JP. Tyrosine codon corresponds to topa quinone at the active site of copper amine oxidases. J Biol Chem. 1992 Apr 25;267(12):7979-82. PubMed PMID: 1569055. 15: Cha JH, Dure LS IV, Sakurai SY, Penney JB, Young AB. 2,4,5-Trihydroxyphenylalanine (6-hydroxy-dopa) displaces [3H]AMPA binding in rat striatum. Neurosci Lett. 1991 Oct 28;132(1):55-8. PubMed PMID: 1664920. 16: Brown DE, McGuirl MA, Dooley DM, Janes SM, Mu D, Klinman JP. The organic functional group in copper-containing amine oxidases. Resonance Raman spectra are consistent with the presence of topa quinone (6-hydroxydopa quinone) in the active site. J Biol Chem. 1991 Mar 5;266(7):4049-51. PubMed PMID: 1900285. 17: Aizenman E, White WF, Loring RH, Rosenberg PA. A 3,4-dihydroxyphenylalanine oxidation product is a non-N-methyl-D-aspartate glutamatergic agonist in rat cortical neurons. Neurosci Lett. 1990 Aug 14;116(1-2):168-71. PubMed PMID: 1979663. 18: Olney JW, Zorumski CF, Stewart GR, Price MT, Wang GJ, Labruyere J. Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases. Exp Neurol. 1990 Jun;108(3):269-72. PubMed PMID: 1972067. 19: Passi S, Picardo M, Nazzaro-Porro M. Comparative cytotoxicity of phenols in vitro. Biochem J. 1987 Jul 15;245(2):537-42. PubMed PMID: 2822025; PubMed Central PMCID: PMC1148155. 20: Morrison ME, Yagi MJ, Cohen G. In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells. Proc Natl Acad Sci U S A. 1985 May;82(9):2960-4. PubMed PMID: 3921968; PubMed Central PMCID: PMC397686.